Conduit Pharmaceuticals Reports Material Agreement and Equity Sales
Ticker: CDTTW · Form: 8-K · Filed: Apr 4, 2025 · CIK: 1896212
| Field | Detail |
|---|---|
| Company | Conduit Pharmaceuticals Inc. (CDTTW) |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-definitive-agreement, unregistered-sales, equity-securities
TL;DR
Conduit Pharma inked a deal and sold stock on 3/31 - check the details!
AI Summary
Conduit Pharmaceuticals Inc. filed an 8-K on April 4, 2025, reporting on two key events that occurred on March 31, 2025: entering into a material definitive agreement and unregistered sales of equity securities. The company, formerly known as Murphy Canyon Acquisition Corp., is incorporated in Delaware and operates in the Pharmaceutical Preparations industry.
Why It Matters
This filing indicates significant corporate activity, including potential new partnerships or financing through definitive agreements and the issuance of equity, which could impact the company's financial structure and future operations.
Risk Assessment
Risk Level: medium — The filing involves unregistered sales of equity, which can sometimes indicate less transparency or potential dilution for existing shareholders.
Key Players & Entities
- Conduit Pharmaceuticals Inc. (company) — Registrant
- Murphy Canyon Acquisition Corp. (company) — Former company name
- March 31, 2025 (date) — Date of earliest event reported
- April 4, 2025 (date) — Filing date
FAQ
What type of material definitive agreement did Conduit Pharmaceuticals Inc. enter into?
The filing does not specify the nature of the material definitive agreement, only that one was entered into on March 31, 2025.
What were the terms of the unregistered sales of equity securities?
The filing states that unregistered sales of equity securities occurred on March 31, 2025, but does not provide specific details on the terms, price, or number of shares sold.
When was Conduit Pharmaceuticals Inc. formerly known as Murphy Canyon Acquisition Corp.?
The company's name was changed from Murphy Canyon Acquisition Corp. on November 30, 2021.
What is Conduit Pharmaceuticals Inc.'s Standard Industrial Classification (SIC) code?
Conduit Pharmaceuticals Inc.'s SIC code is 2834, which corresponds to Pharmaceutical Preparations.
In which state is Conduit Pharmaceuticals Inc. incorporated?
Conduit Pharmaceuticals Inc. is incorporated in Delaware.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding CONDUIT PHARMACEUTICALS INC. (CDTTW).